Influenza Vaccine Feasibility Study in Children With Persistent Asthma

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 10, 2016

Primary Completion Date

February 1, 2017

Study Completion Date

February 1, 2017

Conditions
Asthmatic
Interventions
DRUG

ccIIV4

DRUG

IIV4

Trial Locations (4)

27705

Duke Clinical Vaccine Unit, Durham

30329

Centers for Disease Control and Prevention, Atlanta

37232

Vanderbilt Vaccine Research Program, Nashville

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Duke University

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

Vanderbilt University Medical Center

OTHER